Ensign Peak Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$354K Hold
1,369
﹤0.01% 1067
2025
Q4
$338K Sell
1,369
-3,050
-69% -$642K ﹤0.01% 1073
2025
Q3
$780K Sell
4,419
-2,150
-33% -$322K ﹤0.01% 1158
2025
Q2
$903K Hold
6,569
﹤0.01% 1297
2025
Q1
$1.18M Hold
6,569
﹤0.01% 1158
2024
Q4
$1.03M Hold
6,569
﹤0.01% 1303
2024
Q3
$1.2M Hold
6,569
﹤0.01% 1224
2024
Q2
$1.21M Sell
6,569
-14,348
-69% -$2.41M ﹤0.01% 1162
2024
Q1
$3.72M Buy
20,917
+14,017
+203% +$1.95M 0.01% 718
2023
Q4
$856K Hold
6,900
﹤0.01% 1466
2023
Q3
$800K Buy
6,900
+2,050
+42% +$250K ﹤0.01% 1362
2023
Q2
$569K Buy
+4,850
New +$495K ﹤0.01% 1599
2022
Q4
Sell
-3,670
Closed -$256K 2013
2022
Q3
$256K Buy
+3,670
New +$265K ﹤0.01% 1775
2021
Q4
Sell
-34,596
Closed -$1.81M 2217
2021
Q3
$1.81M Buy
+34,596
New +$2.05M ﹤0.01% 1185

Other funds holding KRYS